Stamford Hospital, residing on the Bennett Medical Center campus, is a 305-bed, not-for-profit hospital and the central facility for Stamford Health. The hospital is regional healthcare facility for Fairfield and Westchester counties, and is the only hospital in the city of Stamford, Connecticut.

During the past decade, Stamford Hospital conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 12 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 10 clinical trials were completed. i.e. 76.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stamford Hospital" #1 sponsor was "Dana-Farber Cancer Institute" with 7 trials, followed by "Stamford Hospital" with 4 trials sponsored, "Exact Sciences Corporation" with 3 trials sponsored, "NewLink Genetics Corporation" with 3 trials sponsored and "Agendia" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stamford Hospital" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "I-Flow" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Stamford Hospital" are "Breast Cancer" (10 trials), "Pancreatic Cancer" (3 trials), "Prostate Cancer" (3 trials), "Abdominal Muscles/Ultrasonography" (2 trials) and "Adult" (2 trials). Many other conditions were trialed in "Stamford Hospital" in a lesser frequency.

Most popular intervention types in "Stamford Hospital" are "Drug" (35 trials), "Other" (12 trials), "Biological" (7 trials), "Device" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Gemcitabine" (5 trials), "Blood Sample Collection" (3 trials), "Carboplatin" (3 trials) and "Docetaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Stamford Hospital" are 39 trials for "All" genders, 11 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Stamford Hospital". undefined are not yet recruiting, 9 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Stamford Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Stamford Hospital, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".

Stamford Hospital has several departments that took part in Clinical trials: "Stamford Hospital/Bennett Cancer Center" - 60 trials, "Hematology Oncology, P.C." - 33 trials, "Carl and Dorothy Bennett Cancer Center at Stamford Hospital" - 8 trials, "Pediatric Pulmonology, LLC" - 2 trials, "Pulmonary Assoc of Stamford" - 2 trials